More evidence East Rise West Sink, US takes the lead! SCMP: Two Chinese drug developers have signed licensing deals that could yield as much as US$2.5 billion in performance-based payments, underscoring growing international confidence in China’s life sciences sector. Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals 更多證據表明，東升西沉證據再添，美國領先衰敗 《南華早報》：兩家中國製藥公司簽署了許可協議，可能產生高達25億美元的績效付費，凸顯了國際社會對中國生命科學領域日益增長的信心。豪森製藥和Leads Biolabs達成25億美元的全球藥品授權協議
https://www.scmp.com/business/article/3329353/chinas-hansoh-and-leads-biolabs-clinch-us25-billion-global-drug-licensing-deals?